| Date Filed | Type | Description |
| 08/17/2023 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 318 shares
@ $66.878, valued at
$21.3k
Sold 5,000 shares
@ $90, valued at
$450k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 12,000 shares
@ $90.4259, valued at
$1.1M
|
|
| 08/10/2023 |
4
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 5,360 shares
@ $93.304, valued at
$500.1k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
4
| Davis George Eric (EVP, Chief Legal Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 11,000 shares
@ $89.4238, valued at
$983.7k
|
|
| 08/09/2023 |
4
| BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 4,000 shares
@ $88.1, valued at
$352.4k
Sold 6,000 shares
@ $88.29, valued at
$529.7k
|
|
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/31/2023 |
8-K
| Quarterly results |
| 06/30/2023 |
4
| Mueller Brian (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 4,602 shares
@ $88.93, valued at
$409.3k
Paid exercise price by delivering 576 shares
@ $88.93, valued at
$51.2k
|
|
| 05/24/2023 |
4
| Slamon Dennis (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| MEIER RICHARD A (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| HOMBACH ROBERT J. (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| Ho Maykin (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| HERON ELAINE J (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| Dere Willard H (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| ANDERSON ELIZABETH M (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/24/2023 |
4
| Alles Mark J (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 05/18/2023 |
4
| Burkhart Erin (GVP, Chief Accounting Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 796 shares
@ $92.02, valued at
$73.2k
|
|
| 05/18/2023 |
4
| Davis George Eric (EVP, Chief Legal Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 317 shares
@ $66.88, valued at
$21.2k
Gifted 210 shares
@ $0 |
|
| 05/17/2023 |
4
| MEIER RICHARD A (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 6,137 shares
@ $93.93, valued at
$576.4k
Exercised 8,500 options to buy
@ $67.81, valued at
$576.4k
|
|
| 05/17/2023 |
4
| HERON ELAINE J (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 6,137 shares
@ $93.93, valued at
$576.4k
Exercised 8,500 options to buy
@ $67.81, valued at
$576.4k
|
|
| 05/16/2023 |
4
| BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 6,337 shares
@ $93.93, valued at
$595.2k
Paid exercise price by delivering 33,644 shares
@ $93.93, valued at
$3.2M
Exercised 39,130 options to buy
@ $67.81, valued at
$2.7M
Exercised 7,370 options to buy
@ $67.81, valued at
$499.8k
|
|
| 05/15/2023 |
4
| BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 24,439 shares
@ $94.55, valued at
$2.3M
Sold 5,561 shares
@ $95.22, valued at
$529.5k
Exercised 30,000 options to buy
@ $67.81, valued at
$2M
|
|
| 05/11/2023 |
4
| BIENAIME JEAN JACQUES (CEO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 317 shares
@ $66.88, valued at
$21.2k
Sold 13,626 shares
@ $94.22, valued at
$1.3M
Sold 14,964 shares
@ $95.49, valued at
$1.4M
Sold 1,410 shares
@ $95.9, valued at
$135.2k
Exercised 30,000 shares
@ $67.81, valued at
$2M
Sold 21,453 shares
@ $94.65, valued at
$2M
Sold 8,547 shares
@ $95.34, valued at
$814.9k
Exercised 30,000 options to buy
@ $67.81, valued at
$2M
|
|
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|